52 results
·
41ms
·
Sources: EU EUDAMED, US FDA
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA Pre-Market Approval
FDA Class 3
·CARTIVA SYNTHETIC CARTILAGE IMPLANT
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA Pre-Market Approval
FDA Class 3
·Cartiva Synthetic Cartilage Implant
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA Pre-Market Approval
FDA Class 3
·Cartiva SCI
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA Pre-Market Approval
FDA Class 3
·Cartiva Synthetic Cartilage Implant (SCI)
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA Pre-Market Approval
FDA Class 3
·CARTIVA SYNTHETIC CARTILAGE IMPLANT
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA Pre-Market Approval
FDA Class 3
·Cartiva Synthetic Cartilage Implant (Cartiva SCI)
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA Pre-Market Approval
FDA Class 3
·Cartiva Synthetic Cartilage Implant
Implant, Cochlear
FDA Pre-Market Approval
FDA Class 3
·NUCLEUS 22 CHANNEL COCHLEAR IMPLANT
Implant, Cochlear
FDA Pre-Market Approval
FDA Class 3
·NUCLEUS 22 CHANNEL COCHLEAR IMPLANT SYSTEM
Anti-Glutamate Receptor (Type Nmda) Ifa
FDA classification
FDA Class 2
·Anti-Glutamate Receptor (Type Nmda) Ifa
Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
FDA classification
FDA Class 3
·Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant
System, Test, Blood Glucose, Over The Counter
FDA classification
FDA Class 2
·System, Test, Blood Glucose, Over The Counter